# Study of Default Options in Advance Directives

> **NCT01817686** · NA · COMPLETED · sponsor: **Corporal Michael J. Crescenz VA Medical Center** · enrollment: 62 (actual)

## Conditions studied

- COPD
- Severe or Very Severe Airflow Obstruction and/or Receiving or Eligible to Receive Long-term Oxygen Therapy
- Idiopathic Pulmonary Fibrosis
- Other Interstitial Lung Disease Without Curative Therapy
- Congestive Heart Failure
- NYHA Class IV or NYHA Class III Plus 1 Hospitalization in the Past Year
- Malignancy
- Any Stage 3B or 4 Solid Tumor

## Interventions

- **OTHER:** Comfort Default AD forms
- **OTHER:** Life Extension Default AD forms
- **OTHER:** Standard Default AD forms

## Key facts

- **NCT ID:** NCT01817686
- **Lead sponsor:** Corporal Michael J. Crescenz VA Medical Center
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2015-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01817686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01817686, "Study of Default Options in Advance Directives". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01817686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*